Work

Camrelizumab plus with nimotuzumab in the second-line treatment of advanced esophageal squamous cell carcinoma: A single-arm, open-label phase II clinical trial.

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16005

Authors: Jin Xia, Xiangrui Meng, Yinghua Ji, Xiuli Yang, Yong-Gui Hong, Junsheng Wang, Donghai Cui, Zhiquan Luo, Feng Wang

Institutions: Anyang Tumor Hospital, Zhengzhou University, First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinxiang Medical University, Nanyang Medical College

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410811466

FWCI: 0.869

Cites:

Cited by: 1

Related to: 10